InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
2.610
+0.140 (5.67%)
At close: May 22, 2026, 4:00 PM EDT
2.560
-0.050 (-1.92%)
After-hours: May 22, 2026, 7:49 PM EDT
InflaRx Market Cap
InflaRx has a market cap or net worth of $384.43 million as of May 22, 2026. Its market cap has increased by 259.28% in one year.
Market Cap
384.43M
Enterprise Value
339.49M
1-Year Change
259.28%
Ranking
Category
Stock Price
$2.61
Market Cap Chart
Since November 8, 2017, InflaRx's market cap has increased from $350.90M to $384.43M, an increase of 9.56%. That is a compound annual growth rate of 1.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 188.70M | 175.88% |
| Dec 31, 2025 | 68.40M | -52.96% |
| Dec 31, 2024 | 145.40M | 51.46% |
| Dec 29, 2023 | 96.00M | -29.93% |
| Dec 30, 2022 | 137.00M | -34.85% |
| Dec 31, 2021 | 210.30M | 60.17% |
| Dec 31, 2020 | 131.30M | 27.72% |
| Dec 31, 2019 | 102.80M | -88.13% |
| Dec 31, 2018 | 866.00M | 76.55% |
| Dec 29, 2017 | 490.50M | 39.78% |
| Nov 8, 2017 | 350.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Replimune Group | 405.43M |
| Lexeo Therapeutics | 401.25M |
| C4 Therapeutics | 392.24M |
| Benitec Biopharma | 385.80M |
| OmniAb | 384.18M |
| Greenwich LifeSciences | 383.08M |
| Artiva Biotherapeutics | 382.39M |
| X4 Pharmaceuticals | 381.05M |